Abstract
Mature human interleukin-11 (HuIL-11) is a cytokine consisting of 178 amino acid residues that results from scission of the N-terminal signal peptide, consisting of 21 amino acid residaues, from the corresponding nascent polypeptide. A DNA fragment encoding a truncated HuIL-11 (trHuIL-11), with an additional 5 amino acid residues removed from the N-terminus, was cloned into vector pGEX-2T between the BamHI site and the EcoRI site. Upon transformation with Escherichia coli BL21, the construct over-produced a glutathione S-transferase (GST)-fused protein in a soluble form after IPTG induction. The fusion protein was initially fractionated with butyl-Sepharose 4 fast flow column and by affinity chromatography using a GSH-Sepharose 4B column. On-site enzymatic release with thrombin gave the target protein at 96% purity as judged by SDS-PAGE and HPLC. Expression of the interleukin as a GST-fused protein thus greatly improved downstream processing. Subsequent biological activity assay suggested that trHuIL-11 had similar activity profile to the naturally produced sample and may be a promising candidate for further development as biopharmaceutical.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Reference
JB Bussel R Mukherjee AJ Stone (2001) ArticleTitleA pilot study of rhuIL-11 treatment of refractory ITP Am. J. Hematol 66 172–177 Occurrence Handle10.1002/1096-8652(200103)66:3<172::AID-AJH1041>3.0.CO;2-Q Occurrence Handle11279623
MS Cairo V Davenport O Bessmertny SC Goldman SL Berg SG Kreissman J Laver V Shen R Secola C Ven Particlevan de GH Reaman (2005) ArticleTitlePhase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study Br. J. Haematol 128 49–58 Occurrence Handle10.1111/j.1365-2141.2004.05281.x Occurrence Handle15606549
MM Cotreau L Stonis A Strahs US Schwertschlag (2004) ArticleTitleA multiple-dose, safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin-11 (oprelvekin) Biopharm. Drug Dispos 25 291–296 Occurrence Handle10.1002/bdd.415 Occurrence Handle15386478
X Du DA Williams (1997) ArticleTitleInterleukin-11: review of molecular, cell biology, and clinical use J. Blood 89 3897–3908
R Ghalib C Levine M Hassan T McClelland J Goss R Stribling P Seu YZ Patt (2003) ArticleTitleRecombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis Hepatology 37 1165–1171 Occurrence Handle10.1053/jhep.2003.50160 Occurrence Handle12717398
JA Hermann MA Hall RN Maini M Feldmann FM Brennan (1998) ArticleTitleImportant immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis Arthritis Rheum 41 1388–1397 Occurrence Handle10.1002/1529-0131(199808)41:8<1388::AID-ART7>3.0.CO;2-F Occurrence Handle9704636
JP Huff BJ Grant CA Penning KF Sullivan (1990) ArticleTitleOptimization of routine transformation of Escherichia coli with plasmid DNA Biotechniques 9 570–577 Occurrence Handle2268424
JA Kaye (1998) ArticleTitleFDA licensure of NEUMEGA to prevent severe chemotherapy-induced thrombocytopenia Stem Cells 2 207–223
R Kurzrock J Cortes DA Thomas S Jeha S Pilat M Talpaz (2001) ArticleTitlePilot study of low-dose interleukin-11 in patients with bone marrow failure J. Clin. Oncol 19 4165–4172 Occurrence Handle11689585
L Moreland R Gugliotti K King W Chase M Weisman T Greco R Fife J Korn R Simms J Tesser J Hillson J Caldwell T Schnitzer D Lyons U Schwertschlag (2001) ArticleTitleResults of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis Arthritis Res 3 247–252 Occurrence Handle10.1186/ar309 Occurrence Handle11438043
BE Sands BD Winston B Salzberg M Safdi C Barish L Wruble R Wilkins M Shapiro US Schwertschlag (2002) ArticleTitleRHIL-11 Crohn’s Study group. Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn’s disease Aliment Pharmacol Ther 16 399–406 Occurrence Handle10.1046/j.1365-2036.2002.01179.x Occurrence Handle11876692
WA Silva SuffixJr DT Covas RA Panepucci R Proto-Siqueira JL Siufi DL Zanette AR Santos MA Zago (2003) ArticleTitleThe profile of gene expression of human marrow mesenchymal stem cells Stem Cells 21 661–669 Occurrence Handle10.1634/stemcells.21-6-661 Occurrence Handle14595126
E Tohjima D Inoue N Yamamoto S Kido Y Ito S Kato Y Takeuchi S Fukumoto T Matsumoto (2003) ArticleTitleDecreased AP-1 activity and interleukin-11 expression by bone marrow stromal cells may be associated with impaired bone formation in aged mice J. Bone Miner. Res 18 1461–1470 Occurrence Handle12929935
K Tohyama Y Yoshida K Ohashi E Sano H Kobayashi K Endo M Naruto T Nakamura (1992) ArticleTitleProduction of multiple growth factors by a newly established human thyroid carcinoma cell line Jpn. J. Cancer Res 83 153–158 Occurrence Handle1372885
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tan, H., Dan, G., Gong, H. et al. Purification and Characterization of Recombinant Truncated Human Interleukin-11 Expressed as Fusion Protein in Escherichia coli. Biotechnol Lett 27, 905–910 (2005). https://doi.org/10.1007/s10529-005-7179-3
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10529-005-7179-3